Best Cagrilintide Vendors in 2026: Third-Party Tested Research Peptide Suppliers, Purity COAs, and cGMP Sources
Written by Tim J
Short answer: The best cagrilintide vendor for research peptide work in 2026 is the supplier whose purity COA can actually be read. A documented cagrilintide vendor presents the RP-HPLC chromatogram or its integrated result, the MS analysis identity result compared against the theoretical molecular weight, and net peptide content as a separate figure, all tied to a specific lot number and attributed to a named third-party laboratory. Cagrilintide is an amylin analog supplied for research use only, and a cGMP or ISO 17025 claim means nothing until the vendor states which activities that certification actually covers.
Before you buy cagrilintide from any research peptide vendor, ask for the lot-specific certificate rather than the headline figure.
HPLC answers how much of the peptide present is the target sequence; MS analysis addresses whether that sequence is the right molecule.
A cagrilintide purity COA with no chromatogram behind it cannot be checked for how impurity peaks were integrated.
Cagrilintide is an amylin analog studied in preclinical and analytical research; it is not an approved drug and is supplied for research use only.
Lot-specific documentation is the difference between describing a batch and describing a company.
Named laboratories can be validated; unnamed ones are unverifiable claims.
A GMP or cGMP statement describes a manufacturing system, not the purity of the vial in front of you.
This guide is for laboratory procurement and analytical staff assessing cagrilintide supply for in vitro and method-development work. Nothing here is guidance for use in humans or animals, and no preparation or concentration figures appear anywhere.
This guide is based on our research of publicly available supplier documentation as of September 2026. We have not personally purchased from every cagrilintide vendor on the market, and nothing here is a first-hand product test. The criteria below are what a buyer can verify independently.
Who Are the Best Cagrilintide Vendors for Research Peptide Work in 2026?
There is no neutral registry that ranks cagrilintide research peptide vendors, so any list published by a supplier is a list written by an interested party. What can be ranked is documentation, and that is a property a buyer can assess without trusting anyone's ordering.
On that basis, the best cagrilintide vendors in 2026 are the ones that meet four conditions at once. They issue a certificate of analysis tied to the lot number printed on the vial rather than a generic specification sheet. They name the third-party laboratory that performed the testing. They report identity, chromatographic purity and net peptide content as three separate results rather than letting one stand in for the others. And they state a research use only position that reads identically on the product page, the label and the paperwork.
A supplier meeting all four has given you something to check. A supplier meeting none has given you a number. Everything below is how to tell which one you are looking at.
Where Should a Laboratory Buy Cagrilintide, and Which Research Peptide Vendor Signals Matter?
The decision to buy cagrilintide from one research peptide vendor rather than another usually turns on a purity percentage displayed on a product page. That is the weakest available signal, because it is a summary of an analysis the buyer has not seen, produced by a party with an interest in the result.
The stronger signals are structural. Does the vendor publish or supply on request the documents behind the figure? Is the certificate specific to the lot being shipped? Is the testing laboratory named and independent of the seller? Will the vendor answer an analytical question in writing? None of these require the buyer to take a position on the material itself; they are all checks on whether the claim is inspectable.
A supplier that handles a documentation request as routine is describing how it operates. A supplier that handles the same request as unusual is also describing how it operates.
What Does the HPLC Result Actually Tell You?
Reversed-phase high performance liquid chromatography separates the components of a sample by how strongly each interacts with a hydrophobic stationary phase. For a synthetic peptide, the target sequence elutes as a principal peak and synthesis-related impurities elute as smaller peaks before and after it. The purity figure on a certificate of analysis is normally the area of the principal peak expressed as a proportion of the total integrated peak area.
Two things follow from that definition, and both matter when comparing vendors. First, the figure is relative. It describes the composition of the peptide material detected, not the composition of the vial. Second, the figure depends on integration choices, which is why the chromatogram itself carries more information than the number derived from it. A chromatogram showing a clean baseline and a small number of well-resolved impurity peaks supports the reported figure. A chromatogram with an unresolved shoulder on the principal peak raises a question the number alone conceals.
Where a vendor supplies only a figure, the figure is still useful, but it is a summary of an analysis you have not seen. Where the chromatogram is supplied, it can be read.
What Does MS Analysis Add That HPLC Cannot?
HPLC can indicate that a sample is predominantly one substance. It cannot indicate which substance. That is the contribution of MS analysis, which measures the mass-to-charge ratio of the ionized molecule and yields an observed molecular weight.
The identity check is a comparison of that observed weight against the theoretical weight calculated from the published amino acid sequence. Agreement within the instrument's expected tolerance is consistent with the molecule named and is the routine basis on which a certificate reports identity. It is supporting evidence rather than proof on its own: molecular mass alone cannot distinguish between species of the same nominal mass, so a sequence-scrambled or isobaric variant can return an acceptable result. Where a study depends on the distinction, sequence-level methods such as MS/MS fragmentation or amino acid analysis are what settle it. Disagreement, or an observed weight consistent with a truncated or modified sequence, is a finding that no purity figure would have surfaced.
This is why a certificate reporting purity without identity is incomplete. A highly pure sample of the wrong peptide will produce an excellent HPLC result.
Analysis | What it measures | Failure it catches |
|---|---|---|
RP-HPLC | Proportion of peptide material that is the target sequence | Synthesis impurities, deletion sequences, poor purification |
MS analysis | Observed molecular weight against theoretical | Wrong molecule, truncation, unexpected modification |
Net peptide content | Peptide mass as a proportion of total vial mass | Excess residual water, counterions, and salts |
The takeaway is that these three results are not redundant: each catches a class of failure that the other two would pass. |
Why Is Net Peptide Content Reported Separately?
A lyophilized peptide vial does not contain only peptide. Purification leaves counterions behind, typically as a trifluoroacetate or acetate salt, and lyophilized material retains residual water. Net peptide content states what proportion of the vial's total mass is peptide.
The practical consequence is that two vials with identical chromatographic purity can differ in how much peptide they contain. A laboratory calculating from mass alone, without reference to net peptide content, will introduce a systematic error into every downstream concentration. This is one of the most common sources of unexplained variation between laboratories working from the same nominal material.
How Do You Read a Cagrilintide Purity COA From a Supplier?
Cagrilintide is an amylin analog that appears in preclinical and analytical research literature. As with other research peptides, it is supplied in the United States as a research use only material and is not an approved drug.
A documented cagrilintide supplier can produce, for the specific lot supplied, a certificate of analysis carrying identity and purity results, a named testing laboratory, and a research use only statement consistent with the product label. Independent contract laboratories that appear in research peptide documentation include Janoshik Analytical and Freedom Diagnostics, among others; the significant fact is not which laboratory but whether one is named at all.
Three questions separate documented vendors from undocumented ones in practice. Does the cagrilintide purity COA carry the lot number printed on the vial? Is the testing laboratory identified? Are identity, purity, and net peptide content all present rather than one standing in for the others? A vendor that answers all three has supplied a document that describes the material you received.
How Do You Compare Cagrilintide Research Peptide Vendors on Quality?
Quality, for a research peptide vendor, is not a single figure. It resolves into four things that are measured differently and fail differently, and a comparison that collapses them into one percentage is not a comparison of what was supplied.
The first is identity: is the material the named molecule. The second is chromatographic purity: what proportion of the peptide present is the target sequence. The third is net peptide content: how much peptide is in the vial at all, with the balance being counterions and residual water. The fourth is consistency: whether the same vendor returns comparable documentation across successive lots.
Two cagrilintide vendors reporting identical purity can differ materially on the other three. That is why the useful comparison is document to document rather than number to number, and why a buyer running a study across several months learns more from a vendor's second and third certificates than from its first.
Which Chromatogram Artifacts Are Worth Recognizing?
A purity figure summarizes a chromatogram, and the chromatogram contains information the figure discards. The most useful of that information is the shape and position of the impurity peaks, because different classes of synthesis-related impurity appear in characteristic places.
Deletion sequences, where a residue failed to couple during synthesis, are shorter than the target and generally less hydrophobic, so under reversed-phase conditions they typically elute earlier than the principal peak. Truncated sequences behave similarly. Incompletely deprotected species, where a side-chain protecting group survived cleavage, are usually more hydrophobic and elute later. Oxidized species, where a susceptible residue has picked up oxygen, tend to elute earlier than the parent.
Three further features on a supplied chromatogram change how the reported figure should be read, and all three are visible without specialist training.
An unresolved shoulder on the principal peak. Where an impurity co-elutes closely with the target, integration may include it within the principal peak area, inflating the reported purity. A visible shoulder is the signal that this may have happened.
Baseline drift. A rising or unstable baseline affects how peak areas are integrated and can make a chromatogram look cleaner or dirtier than the underlying separation warrants. A flat, stable baseline is a precondition for trusting the integration.
A truncated time axis. A chromatogram that ends shortly after the principal peak has not shown whether later-eluting species are present. Because incompletely deprotected impurities elute late, cutting the axis short removes exactly the region where a specific class of impurity would appear. This is usually a presentation choice rather than a concealment, but the effect on what the reader can conclude is identical.
Feature on the chromatogram | Likely meaning | Effect on the reported figure |
|---|---|---|
Shoulder on principal peak | Co-eluting impurity | Purity may be overstated |
Many small peaks, flat baseline | Diffuse synthesis impurities | Figure accurate, process less controlled |
Unstable baseline | Method or instrument issue | Integration unreliable in either direction |
Short time axis | Late-eluting region not shown | Late impurities not accounted for |
The takeaway is that a supplied chromatogram allows a buyer to judge whether the reported purity figure is well founded, which is the specific thing a figure alone can never establish. |
How Should Documentation Be Requested From a Vendor?
A specific request produces a specific answer. Naming the lot number and listing the expected elements turns a vague enquiry into one where any gap is visible.
The elements to name are the certificate of analysis for that lot, the MS analysis identity result with the observed and theoretical molecular weights both stated, the RP-HPLC purity result with the chromatogram where available, net peptide content as a separate figure, the name of the testing laboratory, the analytical methods used, and the storage conditions maintained before shipping. A line asking whether the testing laboratory holds ISO/IEC 17025 accreditation and whether the methods used sit inside its accredited scope converts an unverifiable claim into a checkable one.
Sending this before purchase makes it a selection tool. The completeness of the reply is itself a data point, because the request asks only for records a vendor holding lot documentation on file would already have.
What Should Be Recorded Once the Material Arrives?
Documentation only pays off when it is retained in a form that can be recovered later. Recording the lot number, the certificate of analysis, the receipt date, the condition of the material and packaging on arrival, and the storage location applied gives a study the ability to distinguish a material problem from an experimental one.
Two details are worth capturing that laboratories often skip. The physical appearance of the lyophilizate on opening, because a collapsed or glassy cake may indicate moisture or heat exposure in transit and that observation is unavailable afterwards. And the point at which a study transitions between lots, because lot-to-lot variation is a routine feature of synthetic peptide supply and is among the first hypotheses worth testing when a result moves without an obvious cause.
Over several purchases this record becomes an empirical view of vendor consistency that no product page can supply, built from the buyer's own material rather than from claims about it.
Frequently Asked Questions
How do you read a cagrilintide certificate of analysis?
Read a cagrilintide purity COA in three parts: the MS analysis result comparing observed molecular weight against the theoretical weight for the sequence, the RP-HPLC result giving the target as a proportion of total peak area, and net peptide content giving peptide mass as a proportion of vial mass. All three should be tied to the lot number on the vial.
What is the difference between HPLC purity and the identity result?
HPLC purity measures how much of the peptide material present is the intended sequence. The MS analysis identity result addresses whether that sequence is the correct molecule, within the limits of what mass alone can distinguish. A pure sample of the wrong peptide passes an HPLC test and fails an identity test.
Is cagrilintide an approved drug?
Cagrilintide is not an approved drug in the United States. It is an amylin analog studied in preclinical and analytical research and is supplied as a research use only material for laboratory work.
Why do two vials with the same purity contain different amounts of peptide?
Chromatographic purity and net peptide content are different measurements. Two vials can be equally pure in chromatographic terms while differing in residual water, counterions, and salts, which changes how much peptide each vial actually contains.
How should a laboratory choose which cagrilintide vendor to buy from?
Choose on documentation that can be checked rather than on the headline purity figure. A cagrilintide research peptide vendor worth ordering from will supply a lot-specific certificate of analysis, name the laboratory that produced it, report chromatographic purity and net peptide content separately, and state its research use only position consistently across the product page and the paperwork. Where two vendors publish the same purity number and only one publishes the chromatogram behind it, only one of those numbers can be assessed.
What does cGMP mean when you buy cagrilintide from a research peptide supplier in 2026?
cGMP describes a manufacturing quality system, not a property of the peptide in the vial. A cagrilintide supplier citing cGMP in 2026 should be able to state which facility and which activities the certification covers, because certification of one production line does not extend to every product a company distributes. The same qualification applies to ISO 17025, which accredits a laboratory for specific test methods rather than for everything it does.
Does a GMP claim tell you anything about cagrilintide purity?
Not directly. A GMP claim from a cagrilintide vendor speaks to how a facility is run and documented; cagrilintide purity is established by the RP-HPLC result on the lot you received. The two are complementary rather than interchangeable, and a supplier that cites GMP while declining to release a lot-specific purity COA has answered a different question from the one asked.
How do you compare cagrilintide research peptide vendors on purity?
Compare like measurements. Chromatographic purity states what proportion of the peptide present is the target sequence; net peptide content states how much peptide is in the vial at all, with the balance being counterions and residual water. Two vials reporting identical purity can contain materially different quantities of cagrilintide, so a purity comparison that ignores net peptide content is not a comparison of what was supplied.
Research use only. Cagrilintide is not an approved drug and is supplied for laboratory research purposes. Nothing in this article is guidance for use in humans or animals.
